Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we pri... Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL¿ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects. Mostrar más
Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a...
Jupiter, Florida, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a...
Jupiter, Florida, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a...
Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1491 | -12.425 | 1.2 | 1.38 | 0.91 | 797763 | 1.11461198 | CS |
| 4 | -7.7591 | -88.0715096481 | 8.81 | 9.35 | 0.91 | 1221580 | 3.62243629 | CS |
| 12 | -2.9491 | -73.7275 | 4 | 19.51 | 0.91 | 772321 | 5.74084914 | CS |
| 26 | -2.9491 | -73.7275 | 4 | 19.51 | 0.91 | 772321 | 5.74084914 | CS |
| 52 | -2.9491 | -73.7275 | 4 | 19.51 | 0.91 | 772321 | 5.74084914 | CS |
| 156 | -2.9491 | -73.7275 | 4 | 19.51 | 0.91 | 772321 | 5.74084914 | CS |
| 260 | -2.9491 | -73.7275 | 4 | 19.51 | 0.91 | 772321 | 5.74084914 | CS |
tw0122
2 meses hace
Invest-in-America
2 meses hace
tw0122
2 meses hace
Invest-in-America
2 meses hace
tw0122
2 meses hace
Invest-in-America
2 años hace
makinezmoney
2 años hace
Invest-in-America
2 años hace
spindog
3 años hace
crudeoil24
3 años hace
crudeoil24
3 años hace
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
